에 대한 최신 뉴스 Caduceus Software Sys (OTC:CSOC) 주식

Caduceus Software Systems Corp is a Wyoming-based holding company with its wholly owned subsidiary McLovin's Pet, which manufactures and distributes pet food and accessories. It carries a product lineup across two different categories; One for pet food and the other for pet supplies.

CADUCEUS SOFTWARE SYS CRP by Caduceus Software Systems Corp.

Caduceus Software Systems Corp

CADUCEUS SOFTWARE SYSTEMS, CORP. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CSOC#OTC">CSOC</a>) (&quot;Caduceus&quot;&nbsp;or the &quot;Company&quot;), a consumer goods focused holding company and owner of McLovin&#39;s Pet Food, Inc., announces it has signed an agreement to engage SRAX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAX#NASDAQ">SRAX</a>), a digital marketing and consumer data-management technology company, to assist in its investor outreach and growth initiatives.
<img src="https://www.accesswire.com/users/newswire/images/668224/combined-logos.jpeg" />
&quot;In a recent survey, the Brokerage firm Schwab found that these new investors are not just young people. They are also an older cohort discovering investing for the first time. Generation Investor has a median age of 35, compared with pre-2020 investors whose median age is 48, Schwab said. More than&nbsp;50%&nbsp;of Generation Investor are millennials,&nbsp;22%&nbsp;are Gen X, 16 are Gen Z and&nbsp;11%&nbsp;are baby boomers.&quot;
Source:&nbsp;<a href="https://www.cnbc.com/2021/04/08/a-large-chunk-of-the-retail-investing-crowd-got-their-start-during-the-pandemic-schwab-survey-shows.html">https://www.cnbc.com/2021/04/08/a-large-chunk-of-the-retail-investing-crowd-got-their-start-during-the-pandemic-schwab-survey-shows.html</a>
McLovin&#39;s is a consumer-focused company. It is imperative for a Company like McLovin&#39;s to understand the demographics of the markets is operates in. This partnership will allow the Company to properly tailor the marketing and communication strategies it uses and more importantly to use the most efficient channels to reach out to consumers, shareholders, and investors. SRAX is uniquely positioned as a financial technology and digital marketing company. The Company believes this partnership will propel CSOC and McLovin&#39;s profile even further.
&quot;We have been following SRAX for some time now. The Company&#39;s foray into the crypto token space through BigToken, as well as its expertise in the digital marketing space are impressive achievements. We believe this endeavor is going to be a very successful one and create further value for the Company and its shareholders.&quot;,&nbsp;said Alex Chen, Chief Executive Officer of Caduceus Software Systems, Inc.

News

Contracts

CSOC

SRAX

SRAX Partners With Caduceus; Terms Not Disclosed

Intraday Update

Markets

Movers

Trading Ideas

ADBE

ADNT

ADSK

ADYEY

ADYYF

AIQUY

ALEC

ALLE

ALLT

ALVLF

AMRR

ANSS

APLS

APLT

APPF

APTO

AQUA

ATZAF

BCPC

BILL

BMXMF

BXMT

CBRE

CBSH

CCXI

CDAY

CFBK

CGEN

CHDN

CHGCY

CNNE

CNRMF

CNSWF

CSLLY

CSTI

CTRN

CWEN-A

DNPLY

DOCU

DOOO

DSNKY

ENRT

EONGY

EPAM

ESBS

EXLS

EXPO

FATE

FCPT

FERGY

FICO

FISV

FIVN

FJTSY

Flaherty & Crumrine/Claymore Total Return

FNHM

GLIBA

GLPG

GLPI

GMRE

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HENC

HIMX

Stocks That Hit 52-Week Highs On Tuesday

AFGC

AFTPF

ALSK

ALSWF

ARES

ASPU

BCOW

CFDB

CGJTF

CGUD

CHTR

CLHRF

CLNXF

CLSD

CTLT

CTPTY

DDOG

DNLMY

EDRVF

ELVT

ELYGF

FLXT

GLGDF

GLVMF

GPTRF

GRSFF

HPTO

HRNNF

IBDSF

IMMFF

IMPZY

INGIY

INVH

ITMR

IVME

JAGR

JJAQF

KRNT

LBRDA

LBRDK

LPKFF

MCRI

Stocks That Hit 52-Week Highs On Monday

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

Novelos Therapeutics

Shares of Novelos Therapeutics <a class="ticker" href="/stock/nvlt#">NVLT</a>, the Madison, WI development stage pharmaceutical company, rose 38% Tuesday on 3 times the average daily volume .

Novelos Therapeutics announced Tuesday that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has successfully completed the first cohort in a Phase 1-2 positron emission tomography imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with advanced non-small cell lung cancer. The first cohort comprised three patients dosed with LIGHT at 5 mCi. Anne M. Traynor, M.D., is the trial's principal investigator. Detailed trial results are expected to be presented at a scientific venue at a later date.

"The preliminary results from the first cohort are encouraging. We see strong uptake of LIGHT in cancerous tumors against very low background and have not observed any adverse safety signals," said Dr. Traynor. "Although still early and in a small number of subjects, there is some suggestion that LIGHT imaging was more tumor-selective than the comparator modality 18F-fluorodeoxyglucose PET."

Novelos Therapeutics closed at $1.80 on Tuesday.

3D Eye Solutions

Shares of 3D Eye Solutions <a class="ticker" href="/stock/tdey#">TDEY</a>, the Longwood, FL provider of 3D content conversion services and hardware integration for the 3D stereo and auto-stereo media industry, rose 183% Tuesday on 15 times the average daily volume.

3D Entertainment Holdings dba 3D Eye Solutions announced Monday that it had completed a year of transition which included the signing of a 10 Year worldwide license agreement between 3D Network International, Inc. and 3D Eye Solutions and a significant reduction of debt. The new company will focus on licensing and distribution of 3D Eye Solutions' 3D content worldwide and the future acquisition of optical technologies.

3D Entertainment Holdings reduced its long term liabilities from ($2,306,554) for yearend Dec. 31, 2010 to ($1,425,892,) yearend December 31, 2011. As a result of the debt forgiveness, the Company posted under "Other Income" a gain of $738,010, and its net loss for the Year End 2011 was reduced by $862,652. The Net loss for Year end 2011 was just ($278,948) compared to ($1,141,600) in 2010. 

3D Eye Solutions closed at $.0085 on Tuesday.

Caduceus Software Systems

Shares of Caduceus Software Systems <a class="ticker" href="/stock/csoc#">CSOC</a>, the UK-based software company, rose 321% Tuesday on 43 times the average daily volume. 

Caduceus Software Systems reaffirmed its optimistic views Tuesday on the opportunity it hopes to pursue in the burgeoning Electronic Health Records EHR market. 

1. Around the world, electronic medical records and electronic health records are being implemented to improve patient care, reduce health care expenses and fundamentally change the way in which medicine is practiced. The benefits realized by EMRs in international markets are largely consistent despite vast variations in health care systems, market structures, competitive landscapes and regulatory requirements.

2. Market forces will drive growth of global EMR markets at rates ranging from 6.6 to 9.7 percent across North America, Europe, Latin America and Asia Pacific. The global market is slated to be worth $19.7 billion in 2013:

North America will experience 9.7 percent growth in its EMR market from $7.4 billion in 2010 to $9.8 billion in 2013. With 5,800 hospitals, EMR adoption is beginning to accelerate due to ARRA incentives and penalties.

Asia Pacific's EMR market is expected to grow at 7.6 percent.

Europe, Africa and Latin America will grow at 6.6 percent through 2013 driven by government incentives and a refresh of EMR systems.

3. Emerging markets may be a primary growth driver globally and may have the potential to implement innovative technologies, such as cloud-based EMR solutions.

Caduceus Software Systems closed at $0.0145 on Tuesday.

Comments

Caduceus Software Sys

뉴스

에 대한 최신 뉴스 Caduceus Software Sys (OTC:CSOC) 주식

뉴스

파트너 / 기고자

벤징가 글로벌